Telehealth model versus in-person standard care for persons with type 1 diabetes treated with multiple daily injections: an open-label randomized controlled trial

Telehealth model versus in-person standard care for persons with type 1 diabetes treated with multiple daily injections: an open-label randomized controlled trial

ObjectiveIncreasing evidence indicates that the telehealth (TH) model is noninferior to the in-person approach regarding metabolic control in type 1 diabetes (T1D) and offers advantages such as a decrease in travel time and increased accessibility for shorter/frequent visits. The primary aim of this...

Full description

Bibliographic Details
Main Authors: Sílvia Ballesta, Juan J. Chillarón, Yolanda Inglada, Elisenda Climent, Gemma Llauradó, Juan Pedro-Botet, Francesc Cots, Helena Camell, Juana A. Flores, David Benaiges
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Endocrinology
Subjects:
type 1 diabetes
metabolic control
telehealth
emerging technologies
chronic complications
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1176765/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2023.1176765/full

Similar Items